HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/5/L897    most recent 00116.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (13) Citing Articles via Google Scholar Google Scholar Articles by Marwick, J. A. Articles by Kirkham, P. A. Search for Related Content PubMed PubMed Citation Articles by Marwick, J. A. Articles by Kirkham, P. A.

Cigarette smoke disrupts VEGF₁₆₅-VEGFR-2 receptor signaling complex in rat lungs and patients with COPD: morphological impact of VEGFR-2 inhibition

¹Novartis Institute for Biomedical Research, Horsham, and ²Respiratory Medicine Unit, Medical Research Council Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom; and ³Department of Environmental Medicine, Lung Biology and Disease Program, University of Rochester Medical Center, Rochester, New York

Submitted 14 March 2005 ; accepted in final form 16 November 2005

VEGF is fundamental in the development and maintenance of the vasculature. VEGF₁₆₅ signaling through VEGF receptor (VEGFR)-2/kinase insert domain receptor (KDR) is a highly regulated process involving the formation of a tertiary complex with glypican (GYP)-1 and neuropilin (NRP)-1. Both VEGF and VEGFR-2 expression are reduced in emphysematous lungs; however, the mechanism of regulation of VEGF₁₆₅ signaling through the VEGFR-2 complex in response to cigarette smoke exposure in vivo, and in smokers with and without chronic obstructive pulmonary disease (COPD), is still unknown. We hypothesized that cigarette smoke exposure disrupts the VEGF₁₆₅-VEGFR-2 complex, a potential mechanism in the pathogenesis of emphysema. We show that cigarette smoke exposure reduces NRP-1 and GYP-1 as well as VEGF and VEGFR-2 levels in rat lungs and that VEGF, VEGFR-2, GYP-1, and NRP-1 expression in the lungs of both smokers and patients with COPD are also reduced compared with nonsmokers. Moreover, our data suggest that specific inhibition of VEGFR-2 alone with NVP-AAD777 would appear not to result in emphysema in the adult rat lung. As both VEGF₁₆₅ and VEGFR-2 expression are reduced in emphysematous lungs, decreased GYP-1 and NRP-1 expression may yet further disrupt VEGF₁₆₅-VEGFR-2 signaling. Whether or not this by itself is critical for inducing endothelial cell apoptosis and decreased vascularization of the lung seen in emphysema patients is still unclear at present. However, targeted therapies to restore VEGF₁₆₅-VEGFR-2 complex may promote endothelial cell survival and help to ameliorate emphysema.

kinase insert domain receptor; neuropilin-1; vascular endothelial growth factor receptor-2; chronic obstructive pulmonary disease

This article has been cited by other articles:

				W. MacNee and R. M. Tuder New Paradigms in the Pathogenesis of Chronic Obstructive Pulmonary Disease I Proceedings of the ATS, September 15, 2009; 6(6): 527 - 531. [Abstract] [Full Text] [PDF]

				D. S. Faffe and W. A. Zin Lung Parenchymal Mechanics in Health and Disease Physiol Rev, July 1, 2009; 89(3): 759 - 775. [Abstract] [Full Text] [PDF]

				J. V. Thaikoottathil, R. J. Martin, J. Zdunek, A. Weinberger, J. G. Rino, and H. W. Chu Cigarette smoke extract reduces VEGF in primary human airway epithelial cells Eur. Respir. J., April 1, 2009; 33(4): 835 - 843. [Abstract] [Full Text] [PDF]

				E. Kurtagic, M. P. Jedrychowski, and M. A. Nugent Neutrophil elastase cleaves VEGF to generate a VEGF fragment with altered activity Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L534 - L546. [Abstract] [Full Text] [PDF]

				H. Yao, S.-R. Yang, I. Edirisinghe, S. Rajendrasozhan, S. Caito, D. Adenuga, M. A. O'Reilly, and I. Rahman Disruption of p21 Attenuates Lung Inflammation Induced by Cigarette Smoke, LPS, and fMLP in Mice Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 7 - 18. [Abstract] [Full Text] [PDF]

				I. Edirisinghe, S.-R. Yang, H. Yao, S. Rajendrasozhan, S. Caito, D. Adenuga, C. Wong, A. Rahman, R. P. Phipps, Z.-G. Jin, et al. VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction FASEB J, July 1, 2008; 22(7): 2297 - 2310. [Abstract] [Full Text] [PDF]

				J. L. Wright, M. Cosio, and A. Churg Animal models of chronic obstructive pulmonary disease Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L1 - L15. [Abstract] [Full Text] [PDF]

				S-L Cheng, H-C Wang, C-J Yu, and P-C Yang Increased expression of placenta growth factor in COPD Thorax, June 1, 2008; 63(6): 500 - 506. [Abstract] [Full Text] [PDF]

				K. Emami, R. V. Cadman, J. M. Woodburn, M. C. Fischer, S. J. Kadlecek, J. Zhu, S. Pickup, R. A. Guyer, M. Law, V. Vahdat, et al. Early changes of lung function and structure in an elastase model of emphysema--a hyperpolarized 3He MRI study J Appl Physiol, March 1, 2008; 104(3): 773 - 786. [Abstract] [Full Text] [PDF]

				T. Yoshida and R. M. Tuder Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease Physiol Rev, July 1, 2007; 87(3): 1047 - 1082. [Abstract] [Full Text] [PDF]

				R. M. Tuder, T. Yoshida, I. Fijalkowka, S. Biswal, and I. Petrache Role of Lung Maintenance Program in the Heterogeneity of Lung Destruction in Emphysema Proceedings of the ATS, November 1, 2006; 3(8): 673 - 679. [Abstract] [Full Text] [PDF]